Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Bazedoxifene | hsa00030 | Pentose phosphate pathway | 1.08E-05 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Bazedoxifene | hsa00052 | Galactose metabolism | 1.03E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Bazedoxifene | hsa00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 1.66E-02 | 1 | Q9BQB6 | VKORC1 | More | | Bazedoxifene | hsa00190 | Oxidative phosphorylation | 1.15E-06 | 7 | P13073, Q16718, O15239, P12074, Q13488, P05496, O14521 | COX4I1, NDUFA5, NDUFA1, COX6A1, TCIRG1, ATP5G1, SDHD | More | | Bazedoxifene | hsa00220 | Arginine biosynthesis | 1.97E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Bazedoxifene | hsa00230 | Purine metabolism | 1.81E-02 | 2 | P20839, Q02153 | IMPDH1, GUCY1B3 | More | | Bazedoxifene | hsa00250 | Alanine, aspartate and glutamate metabolism | 1.97E-02 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Bazedoxifene | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Bazedoxifene | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Bazedoxifene | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Bazedoxifene | hsa00500 | Starch and sucrose metabolism | 1.67E-02 | 2 | O43451, P06737 | MGAM, PYGL | More | | Bazedoxifene | hsa00512 | Mucin type O-glycan biosynthesis | 4.86E-02 | 2 | O95395, Q9NY28 | GCNT3, GALNT8 | More | | Bazedoxifene | hsa00520 | Amino sugar and nucleotide sugar metabolism | 2.24E-02 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Bazedoxifene | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 3.43E-02 | 1 | Q9NY97 | B3GNT2 | More | | Bazedoxifene | hsa00561 | Glycerolipid metabolism | 2.21E-02 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | | Bazedoxifene | hsa00565 | Ether lipid metabolism | 3.94E-02 | 1 | Q8N661 | TMEM86B | More | | Bazedoxifene | hsa00600 | Sphingolipid metabolism | 3.96E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Bazedoxifene | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.62E-04 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Bazedoxifene | hsa00730 | Thiamine metabolism | 5.29E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Bazedoxifene | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Bazedoxifene | hsa00830 | Retinol metabolism | 4.40E-02 | 1 | P00325 | ADH1B | More | | Bazedoxifene | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Bazedoxifene | hsa00910 | Nitrogen metabolism | 1.97E-02 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Bazedoxifene | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Bazedoxifene | hsa00983 | Drug metabolism - other enzymes | 8.82E-04 | 4 | P20839, P32320, P05164, Q16772 | IMPDH1, CDA, MPO, GSTA3 | More | | Bazedoxifene | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Bazedoxifene | hsa01210 | 2-Oxocarboxylic acid metabolism | 3.43E-02 | 1 | P50213 | IDH3A | More | | Bazedoxifene | hsa01230 | Biosynthesis of amino acids | 2.22E-03 | 4 | P51854, P60891, Q99707, P37837 | TKTL1, PRPS1, MTR, TALDO1 | More | | Bazedoxifene | hsa01240 | Biosynthesis of cofactors | 2.52E-02 | 2 | Q9BQB6, P14550 | VKORC1, AKR1A1 | More | | Bazedoxifene | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 1.82E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa01522 | Endocrine resistance | 2.16E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa01523 | Antifolate resistance | 1.43E-03 | 2 | Q92820, P04818 | GGH, TYMS | More | | Bazedoxifene | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Bazedoxifene | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Bazedoxifene | hsa03010 | Ribosome | 1.95E-06 | 15 | P62753, P39019, P42677, P62906, P62917, P46776, Q9H0U6, Q07020, P61513, Q02878, P63173, P27635, P05386, P62249, P23396 | RPS6, RPS19, RPS27, RPL10A, RPL8, RPL27A, MRPL18, RPL18, RPL37A, RPL6, RPL38, RPL10, RPLP1, RPS16, RPS3 | More | | Bazedoxifene | hsa03013 | RNA transport | 1.06E-07 | 19 | P62826, O14980, P52298, Q09161, O14893, P61326, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, Q14152, O75822, P78345, P20042, Q14240, P23588, Q9Y6A5, Q14232 | RAN, XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, RNPS1, NXF1, NUP54, NUP214, UBE2I, EIF3A, EIF3J, RPP38, EIF2S2, EIF4A2, EIF4B, TACC3, EIF2B1 | More | | Bazedoxifene | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Bazedoxifene | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Bazedoxifene | hsa03040 | Spliceosome | 4.48E-04 | 10 | Q14562, O43143, O60508, P17844, P51991, P61978, Q07955, Q01130, Q13243, P11142 | DHX8, DHX15, CDC40, DDX5, HNRPA3, HNRPK, SFRS1, SFRS2, SFRS5, HSPA8 | More | | Bazedoxifene | hsa03060 | Protein export | 4.42E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Bazedoxifene | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | | Bazedoxifene | hsa03450 | Non-homologous end-joining | 4.21E-02 | 1 | P13010 | XRCC5 | More | | Bazedoxifene | hsa04010 | MAPK signaling pathway | 4.15E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04014 | Ras signaling pathway | 3.82E-03 | 8 | Q9NRA1, P08069, Q13009, P0DP23, P62873, P63218, P50151, P19174 | PDGFC, IGF1R, TIAM1, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Bazedoxifene | hsa04015 | Rap1 signaling pathway | 2.99E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04020 | Calcium signaling pathway | 1.60E-02 | 5 | Q96DU7, Q08828, Q13557, P21860, P05141 | ITPKC, ADCY1, CAMK2D, ERBB3, SLC25A5 | More | | Bazedoxifene | hsa04060 | Cytokine-cytokine receptor interaction | 4.62E-02 | 3 | P01584, Q13651, P61073 | IL1B, IL10RA, CXCR4 | More | | Bazedoxifene | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Bazedoxifene | hsa04062 | Chemokine signaling pathway | 1.17E-04 | 14 | P25024, P25025, P09341, P19875, P07948, P42338, P19174, P62873, P63218, P50151, Q13009, P14598, P42224, P25963 | CXCR1, CXCR2, CXCL1, CXCL2, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, TIAM1, NCF1, STAT1, NFKBIA | More | | Bazedoxifene | hsa04064 | NF-kappa B signaling pathway | 1.69E-03 | 11 | P14778, P01584, P19174, Q04759, P06239, P63279, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | IL1R1, IL1B, PLCG1, PRKCQ, LCK, UBE2I, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Bazedoxifene | hsa04066 | HIF-1 signaling pathway | 2.16E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04068 | FoxO signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04070 | Phosphatidylinositol signaling system | 2.93E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Bazedoxifene | hsa04071 | Sphingolipid signaling pathway | 6.08E-04 | 5 | P21453, Q9H228, P01375, Q13362, Q9UQC2 | S1PR1, EDG8, TNF, PPP2R5C, GAB2 | More | | Bazedoxifene | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Bazedoxifene | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Bazedoxifene | hsa04110 | Cell cycle | 1.97E-05 | 7 | P06493, O60566, O75293, P30304, P33981, P42773, P01106 | CDK1, BUB1B, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | | Bazedoxifene | hsa04114 | Oocyte meiosis | 2.99E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04120 | Ubiquitin mediated proteolysis | 2.51E-03 | 6 | Q14145, Q13042, P62837, Q15751, O95071, P0CG47 | KEAP1, CDC16, UBE2D2, HERC1, UBR5, UBB | More | | Bazedoxifene | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Bazedoxifene | hsa04137 | Mitophagy - animal | 9.52E-03 | 2 | Q07817, P0CG47 | BCL2L1, UBB | More | | Bazedoxifene | hsa04140 | Autophagy - animal | 2.82E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04141 | Protein processing in endoplasmic reticulum | 1.93E-06 | 16 | P18848, P30101, P07384, O95487, Q15437, Q15436, P60604, Q99941, P11142, P07900, P08238, Q9NR31, P14625, O95816, Q9H173, Q9UNL2 | ATF4, PDIA3, CAPN1, SEC24B, SEC23B, SEC23A, UBE2G2, CREBL1, HSPA8, HSP90AA1, HSP90AB1, SAR1A, HSP90B1, BAG2, SIL1, SSR3 | More | | Bazedoxifene | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Bazedoxifene | hsa04144 | Endocytosis | 2.12E-03 | 11 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, P01889, P10321, P49418, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, HLA-B, HLA-C, AMPH, SNX12 | More | | Bazedoxifene | hsa04145 | Phagosome | 2.72E-06 | 15 | P11215, P60709, Q15075, Q15080, P14598, Q71U36, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765, P01889, P10321 | ITGAM, ACTB, EEA1, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB, HLA-B, HLA-C | More | | Bazedoxifene | hsa04150 | mTOR signaling pathway | 2.32E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04151 | PI3K-Akt signaling pathway | 1.04E-04 | 17 | P62753, P43657, P27348, P09603, Q9GZP0, P07900, P14625, P63218, P50151, P13612, O15335, Q16363, Q13751, P22105, Q99941, P18848, O00141 | RPS6, P2RY5, YWHAQ, CSF1, PDGFD, HSP90AA1, HSP90B1, GNG5, GNG10, ITGA4, CHAD, LAMA4, LAMB3, TNXB, CREBL1, ATF4, SGK | More | | Bazedoxifene | hsa04152 | AMPK signaling pathway | 1.99E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04210 | Apoptosis | 3.58E-02 | 4 | O76075, P01375, Q9NR28, Q16548 | DFFB, TNF, DIABLO, BCL2A1 | More | | Bazedoxifene | hsa04211 | Longevity regulating pathway | 5.33E-03 | 4 | P08069, P51828, Q99941, P18848 | IGF1R, ADCY7, CREBL1, ATF4 | More | | Bazedoxifene | hsa04213 | Longevity regulating pathway - multiple species | 9.82E-04 | 8 | P42338, P08069, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IGF1R, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Bazedoxifene | hsa04215 | Apoptosis - multiple species | 1.56E-02 | 2 | Q13489, P10415 | BIRC3, BCL2 | More | | Bazedoxifene | hsa04217 | Necroptosis | 2.24E-04 | 12 | P01375, P01568, P48023, Q13489, P42224, Q14765, P08238, Q6FI13, Q99878, Q93077, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, STAT1, STAT4, HSP90AB1, H2AC18; H2AC19, H2AC14, HIST1H2AC, CHMP2A, PPID | More | | Bazedoxifene | hsa04218 | Cellular senescence | 3.71E-03 | 6 | P01106, O75293, P30304, P06493, P01889, P10321 | MYC, GADD45B, CDC25A, CDK1, HLA-B, HLA-C | More | | Bazedoxifene | hsa04260 | Cardiac muscle contraction | 4.02E-02 | 2 | P09493, P14927 | TPM1, UQCRB | More | | Bazedoxifene | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.33E-03 | 7 | P07550, P51828, P22694, Q99941, P18848, Q13362, Q13557 | ADRB2, ADCY7, PRKACB, CREBL1, ATF4, PPP2R5C, CAMK2D | More | | Bazedoxifene | hsa04270 | Vascular smooth muscle contraction | 9.46E-04 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Bazedoxifene | hsa04340 | Hedgehog signaling pathway | 3.32E-02 | 2 | P49841, P22694 | GSK3B, PRKACB | More | | Bazedoxifene | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Bazedoxifene | hsa04360 | Axon guidance | 1.50E-02 | 3 | P20827, P23528, Q06124 | EFNA1, CFL1, PTPN11 | More | | Bazedoxifene | hsa04371 | Apelin signaling pathway | 7.95E-04 | 7 | P62873, P63218, P50151, Q13370, Q14344, P84022, P0DP23 | GNB1, GNG5, GNG10, PDE3B, GNA13, SMAD3, CALM1 | More | | Bazedoxifene | hsa04390 | Hippo signaling pathway | 2.08E-02 | 3 | P84022, Q13485, Q13489 | SMAD3, SMAD4, BIRC3 | More | | Bazedoxifene | hsa04510 | Focal adhesion | 3.48E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04512 | ECM-receptor interaction | 4.41E-02 | 3 | Q13751, P13612, O15335 | LAMB3, ITGA4, CHAD | More | | Bazedoxifene | hsa04514 | Cell adhesion molecules | 3.29E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Bazedoxifene | hsa04520 | Adherens junction | 8.29E-03 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04530 | Tight junction | 2.08E-02 | 3 | P63261, Q9Y478, Q92974 | ACTG1, PRKAB1, ARHGEF2 | More | | Bazedoxifene | hsa04540 | Gap junction | 1.08E-02 | 4 | Q13509, P68371, Q71U36, Q9NRA1 | TUBB3, TUBB2C, TUBA1A, PDGFC | More | | Bazedoxifene | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 1.99E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04610 | Complement and coagulation cascades | 7.11E-07 | 2 | P00734, P0C0L4 | F2, C4A | More | | Bazedoxifene | hsa04612 | Antigen processing and presentation | 2.38E-05 | 11 | P13765, P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01889, P10321, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, HLA-B, HLA-C, TNF | More | | Bazedoxifene | hsa04613 | Neutrophil extracellular trap formation | 3.82E-03 | 16 | O60603, P05164, P08246, Q9UM07, Q13547, Q92769, P04908, Q93077, P68431, Q15080, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Bazedoxifene | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Bazedoxifene | hsa04623 | Cytosolic DNA-sensing pathway | 3.84E-05 | 4 | P01584, P01568, P25963, Q8NHW4 | IL1B, IFNA21, NFKBIA, CCL4L2 | More | | Bazedoxifene | hsa04625 | C-type lectin receptor signaling pathway | 4.80E-02 | 6 | Q9ULY5, P20749, Q14643, P01375, Q13191, Q16539 | CLEC4E, BCL3, ITPR1, TNF, CBLB, MAPK14 | More | | Bazedoxifene | hsa04640 | Hematopoietic cell lineage | 3.49E-05 | 16 | P13612, P21926, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375 | ITGA4, CD9, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF | More | | Bazedoxifene | hsa04650 | Natural killer cell mediated cytotoxicity | 6.50E-09 | 17 | P19174, P01375, P78314, P06239, O60880, P20963, Q29983, P10321, P01889, P42338, Q13241, P26718, O14931, O75015, P26717, Q14953, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, MICA, HLA-C, HLA-B, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P01375 | TNF | Tumor necrosis factor | -0.755 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.809 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | Q13547 | HDAC1 | Histone deacetylase 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.786 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.81 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.727 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | Q29983 | MICA | MHC class I polypeptide-related sequence A | 0.774 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | P10321 | HLA-C | HLA class I histocompatibility antigen, C alpha chain | 0.774 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | 0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | Q13547 | HDAC1 | Histone deacetylase 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.807 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.856 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.838 | Q13547 | HDAC1 | Histone deacetylase 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.772 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.879 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.701 | Q13547 | HDAC1 | Histone deacetylase 1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.735 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.893 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.72 | P07550 | ADRB2 | Beta-2 adrenergic receptor | Q14953 | KIR2DS5 | Killer cell immunoglobulin-like receptor 2DS5 | 0.815 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.838 | P07550 | ADRB2 | Beta-2 adrenergic receptor | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.72 |
| Bazedoxifene | hsa04657 | IL-17 signaling pathway | 2.69E-05 | 11 | P25963, O00463, Q16539, P49841, P09341, P19875, P14780, P04141, P80188, P01375, P06702 | NFKBIA, TRAF5, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, CSF2, LCN2, TNF, S100A9 | More | | Bazedoxifene | hsa04658 | Th1 and Th2 cell differentiation | 8.90E-06 | 13 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Bazedoxifene | hsa04659 | Th17 cell differentiation | 1.32E-06 | 17 | P25963, Q04759, Q16539, P19174, P06239, P42224, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Bazedoxifene | hsa04660 | T cell receptor signaling pathway | 1.06E-04 | 14 | P01375, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Bazedoxifene | hsa04664 | Fc epsilon RI signaling pathway | 2.60E-04 | 6 | P04141, Q9UQC2, P07948, P19174, P09917, P20292 | CSF2, GAB2, LYN, PLCG1, ALOX5, ALOX5AP | More | | Bazedoxifene | hsa04666 | Fc gamma R-mediated phagocytosis | 9.92E-03 | 6 | P23528, P06396, O14494, P14598, P49418, P17252 | CFL1, GSN, PLPP1, NCF1, AMPH, PRKCA | More | | Bazedoxifene | hsa04668 | TNF signaling pathway | 3.55E-02 | 4 | P01375, P18848, P19875, P14780 | TNF, ATF4, CXCL2, MMP9 | More | | Bazedoxifene | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Bazedoxifene | hsa04713 | Circadian entrainment | 2.18E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Bazedoxifene | hsa04714 | Thermogenesis | 8.70E-07 | 14 | Q16539, P15336, Q08828, P51828, P63261, P62753, P33121, Q9Y478, P13073, P12074, O15239, Q16718, O14521, P05496 | MAPK14, ATF2, ADCY1, ADCY7, ACTG1, RPS6, ACSL1, PRKAB1, COX4I1, COX6A1, NDUFA1, NDUFA5, SDHD, ATP5G1 | More | | Bazedoxifene | hsa04721 | Synaptic vesicle cycle | 3.15E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Bazedoxifene | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Bazedoxifene | hsa04724 | Glutamatergic synapse | 3.88E-04 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | | Bazedoxifene | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Bazedoxifene | hsa04726 | Serotonergic synapse | 3.80E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Bazedoxifene | hsa04727 | GABAergic synapse | 2.40E-04 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Bazedoxifene | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Bazedoxifene | hsa04730 | Long-term depression | 2.00E-03 | 3 | Q14344, P08069, P07948 | GNA13, IGF1R, LYN | More | | Bazedoxifene | hsa04744 | Phototransduction | 2.97E-04 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Bazedoxifene | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.85E-04 | 9 | P14778, P01584, Q08828, P51828, P19174, P42338, P24723, Q04759, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1 | More | | Bazedoxifene | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Bazedoxifene | hsa04911 | Insulin secretion | 6.24E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Bazedoxifene | hsa04912 | GnRH signaling pathway | 6.28E-04 | 9 | Q08828, P51828, P18848, Q13557, Q16539, Q99759, Q9Y6R4, Q14643, P22694 | ADCY1, ADCY7, ATF4, CAMK2D, MAPK14, MAP3K3, MAP3K4, ITPR1, PRKACB | More | | Bazedoxifene | hsa04913 | Ovarian steroidogenesis | 7.72E-03 | 3 | P42330, P22694, P08069 | AKR1C3, PRKACB, IGF1R | More | | Bazedoxifene | hsa04914 | Progesterone-mediated oocyte maturation | 2.16E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa04915 | Estrogen signaling pathway | 4.95E-04 | 9 | Q99941, P18848, Q08828, P51828, P07900, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Bazedoxifene | hsa04916 | Melanogenesis | 4.80E-02 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | | Bazedoxifene | hsa04918 | Thyroid hormone synthesis | 1.98E-04 | 5 | P51828, Q99941, P18848, P14625, P02768 | ADCY7, CREBL1, ATF4, HSP90B1, ALB | More | | Bazedoxifene | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Bazedoxifene | hsa04920 | Adipocytokine signaling pathway | 3.24E-04 | 9 | P25963, Q06124, P33121, Q9Y478, Q04759, Q15831, P20333, Q9Y4H2, P01375 | NFKBIA, PTPN11, ACSL1, PRKAB1, PRKCQ, STK11, TNFRSF1B, IRS2, TNF | More | | Bazedoxifene | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Bazedoxifene | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Bazedoxifene | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Bazedoxifene | hsa04926 | Relaxin signaling pathway | 2.06E-03 | 6 | Q99941, P18848, P22694, P14780, P51828, P30679 | CREBL1, ATF4, PRKACB, MMP9, ADCY7, GNA15 | More | | Bazedoxifene | hsa04927 | Cortisol synthesis and secretion | 2.72E-04 | 4 | Q99941, P18848, P51828, P22694 | CREBL1, ATF4, ADCY7, PRKACB | More | | Bazedoxifene | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Bazedoxifene | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Bazedoxifene | hsa04932 | Non-alcoholic fatty liver disease | 3.23E-06 | 13 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, P12074, O15239, Q16718, O95298, O14521 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFA5, NDUFC2, SDHD | More | | Bazedoxifene | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 1.25E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Bazedoxifene | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Bazedoxifene | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Bazedoxifene | hsa04940 | Type I diabetes mellitus | 4.29E-04 | 4 | P48023, P01889, P10321, P01375 | FASLG, HLA-B, HLA-C, TNF | More | | Bazedoxifene | hsa04962 | Vasopressin-regulated water reabsorption | 7.22E-03 | 2 | P52566, P62491 | ARHGDIB, RAB11A | More | | Bazedoxifene | hsa04970 | Salivary secretion | 2.43E-03 | 6 | P07550, Q08828, P51828, P22694, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, CALM1, CAMP | More | | Bazedoxifene | hsa04971 | Gastric acid secretion | 4.44E-02 | 2 | P51828, P15311 | ADCY7, VIL2 | More | | Bazedoxifene | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Bazedoxifene | hsa04975 | Fat digestion and absorption | 3.43E-02 | 1 | O14494 | PLPP1 | More | | Bazedoxifene | hsa04976 | Bile secretion | 1.90E-04 | 6 | O43315, Q08828, P51828, P22694, P08183, Q14032 | AQP9, ADCY1, ADCY7, PRKACB, ABCB1, BAAT | More | | Bazedoxifene | hsa05010 | Alzheimer disease | 1.19E-03 | 15 | O15239, P05496, P13073, P12074, O15399, Q9NZJ5, Q13564, P01584, P18848, Q71U36, P09603, P05141, P21796, P28070, P43686 | NDUFA1, ATP5G1, COX4I1, COX6A1, GRIN2D, EIF2AK3, APPBP1, IL1B, ATF4, TUBA1A, CSF1, SLC25A5, VDAC1, PSMB4, PSMC4 | More | | Bazedoxifene | hsa05012 | Parkinson disease | 1.23E-04 | 15 | O15239, P13073, P12074, P05496, P05141, P60604, P18848, P28070, P43686, P19174, P0DP23, Q13557, Q71U36, Q13509, P68371 | NDUFA1, COX4I1, COX6A1, ATP5G1, SLC25A5, UBE2G2, ATF4, PSMB4, PSMC4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3, TUBB2C | More | | Bazedoxifene | hsa05014 | Amyotrophic lateral sclerosis | 2.84E-03 | 10 | P20333, O15239, P13073, P12074, P05496, P18848, P28070, P43686, P35658, Q9UBU9 | TNFRSF1B, NDUFA1, COX4I1, COX6A1, ATP5G1, ATF4, PSMB4, PSMC4, NUP214, NXF1 | More | | Bazedoxifene | hsa05016 | Huntington disease | 3.22E-04 | 13 | O15239, O95298, P13073, P12074, P05496, P24928, P30876, P62487, P05141, O75460, P28070, P43686, O00232 | NDUFA1, NDUFC2, COX4I1, COX6A1, ATP5G1, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1, PSMB4, PSMC4, PSMD12 | More | | Bazedoxifene | hsa05020 | Prion disease | 2.54E-05 | 15 | P01584, P46531, O15239, Q16718, O14521, P05496, P13073, P12074, P18848, P05141, P28070, P43686, P49841, P51636, Q16539 | IL1B, NOTCH1, NDUFA1, NDUFA5, SDHD, ATP5G1, COX4I1, COX6A1, ATF4, SLC25A5, PSMB4, PSMC4, GSK3B, CAV2, MAPK14 | More | | Bazedoxifene | hsa05022 | Pathways of neurodegeneration - multiple diseases | 7.82E-05 | 17 | P49841, O15239, Q16718, O14521, P13073, P12074, P05496, P18848, Q13561, P05141, P20333, Q16539, P01584, Q08752, Q13557, P28070, P43686 | GSK3B, NDUFA1, NDUFA5, SDHD, COX4I1, COX6A1, ATP5G1, ATF4, DCTN2, SLC25A5, TNFRSF1B, MAPK14, IL1B, PPID, CAMK2D, PSMB4, PSMC4 | More | | Bazedoxifene | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Bazedoxifene | hsa05031 | Amphetamine addiction | 8.84E-04 | 5 | Q13557, P22694, Q99941, P18848, Q13547 | CAMK2D, PRKACB, CREBL1, ATF4, HDAC1 | More | | Bazedoxifene | hsa05032 | Morphine addiction | 7.62E-04 | 6 | P62873, P63218, P50151, Q13370, Q07343, P43250 | GNB1, GNG5, GNG10, PDE3B, PDE4B, GRK6 | More | | Bazedoxifene | hsa05034 | Alcoholism | 3.30E-02 | 2 | Q96RR4, P84243 | CAMKK2, H3F3A | More | | Bazedoxifene | hsa05110 | Vibrio cholerae infection | 4.50E-03 | 4 | Q13488, P17252, P19174, P60709 | TCIRG1, PRKCA, PLCG1, ACTB | More | | Bazedoxifene | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 7.88E-05 | 8 | P25963, Q13488, P09341, P19875, P19174, P25024, P25025, P07948 | NFKBIA, TCIRG1, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Bazedoxifene | hsa05130 | Pathogenic Escherichia coli infection | 1.44E-03 | 10 | Q71U36, P16333, Q92974, Q13509, P68371, P63261, Q14344, P25963, Q06124, O95487 | TUBA1A, NCK1, ARHGEF2, TUBB3, TUBB2C, ACTG1, GNA13, NFKBIA, PTPN11, SEC24B | More | | Bazedoxifene | hsa05132 | Salmonella infection | 3.14E-04 | 14 | P51617, P25963, P08238, Q9UJU2, Q13489, P10415, O75369, O60603, Q9BQS8, Q13561, Q71U36, Q13509, P68371, P49754 | IRAK1, NFKBIA, HSP90AB1, LEF1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DCTN2, TUBA1A, TUBB3, TUBB2C, VPS41 | More | | Bazedoxifene | hsa05133 | Pertussis | 2.95E-03 | 2 | P0DP23, P0C0L4 | CALM1, C4A | More | | Bazedoxifene | hsa05134 | Legionellosis | 1.05E-04 | 8 | P01584, P25963, Q9NR31, P11215, P0DMV8, P11142, P09341, P19875 | IL1B, NFKBIA, SAR1A, ITGAM, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Bazedoxifene | hsa05140 | Leishmaniasis | 1.63E-06 | 13 | P13612, O75015, P14598, P11215, P42224, P13765, O60603, P25963, P01375, P29350, Q16539, P51617, Q15080 | ITGA4, FCGR3B, NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MAPK14, IRAK1, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13612 | ITGA4 | Integrin alpha-4 | -0.771 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.893 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.818 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.711 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.798 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.785 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P11215 | ITGAM | Integrin alpha-M | -0.78 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.81 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.714 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.787 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.73 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | O60603 | TLR2 | Toll-like receptor 2 | 0.867 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.841 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.865 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.768 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P01375 | TNF | Tumor necrosis factor | 0.711 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P01375 | TNF | Tumor necrosis factor | 0.774 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 1 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 0.856 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 0.808 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.71 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.752 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.758 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.764 |
| Bazedoxifene | hsa05143 | African trypanosomiasis | 3.01E-03 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Bazedoxifene | hsa05144 | Malaria | 9.55E-04 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Bazedoxifene | hsa05145 | Toxoplasmosis | 2.78E-02 | 3 | P25963, P10415, Q13489 | NFKBIA, BCL2, BIRC3 | More | | Bazedoxifene | hsa05146 | Amoebiasis | 8.90E-07 | 13 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P30679, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Bazedoxifene | hsa05152 | Tuberculosis | 8.59E-04 | 15 | Q13488, Q99437, P13473, P0DP23, P42224, P48382, P25208, O60603, P01375, P10415, P13765, P01568, P49913, Q9UDY8, P51617 | TCIRG1, ATP6V0B, LAMP2, CALM1, STAT1, RFX5, NFYB, TLR2, TNF, BCL2, HLA-DOB, IFNA21, CAMP, MALT1, IRAK1 | More | | Bazedoxifene | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Bazedoxifene | hsa05161 | Hepatitis B | 9.85E-04 | 7 | Q99941, P18848, P25963, Q13485, P10415, P27348, P84022 | CREBL1, ATF4, NFKBIA, SMAD4, BCL2, YWHAQ, SMAD3 | More | | Bazedoxifene | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Bazedoxifene | hsa05163 | Human cytomegalovirus infection | 6.65E-05 | 15 | P25963, P62873, P63218, P50151, P0DP23, Q14344, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, Q13651, P30101, P01568 | NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, IL10RA, PDIA3, IFNA21 | More | | Bazedoxifene | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.51E-06 | 13 | P01568, P42224, P25963, P01889, P10321, P62873, P63218, P50151, P19174, P07948, Q29983, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, HLA-B, HLA-C, GNB1, GNG5, GNG10, PLCG1, LYN, MICA, CSF2, CALM1 | More | | Bazedoxifene | hsa05168 | Herpes simplex virus 1 infection | 4.84E-04 | 14 | P25963, P01568, Q05823, P42224, Q07955, Q01130, Q13243, Q13489, P30101, Q13398, Q9HCX3, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PDIA3, ZNF211, ZNF304, ZNF140, ZNF189, ZNF212 | More | | Bazedoxifene | hsa05169 | Epstein-Barr virus infection | 4.39E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Bazedoxifene | hsa05170 | Human immunodeficiency virus 1 infection | 7.42E-07 | 23 | P01889, P10321, P62873, P63218, P50151, P0DP23, P01375, P17252, O00463, P30101, Q14643, P01568, P51617, P25963, O60603, Q13315, P19174, P23528, Q9NQU5, P10415, Q93034, Q9Y6Q5, P20333 | HLA-B, HLA-C, GNB1, GNG5, GNG10, CALM1, TNF, PRKCA, TRAF5, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, PLCG1, CFL1, PAK6, BCL2, CUL5, AP1M2, TNFRSF1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | 0.774 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | P10321 | HLA-C | HLA class I histocompatibility antigen, C alpha chain | 0.774 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.798 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.777 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P0DP23 | CALM1 | Calmodulin-1 | -0.772 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P01375 | TNF | Tumor necrosis factor | 0.711 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P17252 | PRKCA | Protein kinase C alpha type | 0.844 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.773 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.83 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.858 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P01568 | IFNA21 | Interferon alpha-21 | -0.733 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P01568 | IFNA21 | Interferon alpha-21 | 0.721 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | -0.71 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.865 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | Q13315 | ATM | Serine-protein kinase ATM | -0.71 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P23528 | CFL1 | Cofilin-1 | 0.741 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | 0.75 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | 0.924 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | Q93034 | CUL5 | Cullin-5 | -0.766 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q93034 | CUL5 | Cullin-5 | 0.704 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | 0.709 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.901 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.778 |
| Bazedoxifene | hsa05171 | Coronavirus disease - COVID-19 | 1.05E-06 | 20 | P01375, P01584, P51617, P25963, P42224, P23396, P62753, P62249, P39019, P42677, P62906, Q02878, P62917, P27635, Q07020, P46776, P61513, P63173, P05386, P04141 | TNF, IL1B, IRAK1, NFKBIA, STAT1, RPS3, RPS6, RPS16, RPS19, RPS27, RPL10A, RPL6, RPL8, RPL10, RPL18, RPL27A, RPL37A, RPL38, RPLP1, CSF2 | More | | Bazedoxifene | hsa05200 | Pathways in cancer | 1.99E-03 | 15 | P08238, P42224, P25963, P19174, P43246, P84022, P20585, P62873, P63218, P50151, Q14344, O75293, P0DP23, P01568, P14784 | HSP90AB1, STAT1, NFKBIA, PLCG1, MSH2, SMAD3, MSH3, GNB1, GNG5, GNG10, GNA13, GADD45B, CALM1, IFNA21, IL2RB | More | | Bazedoxifene | hsa05202 | Transcriptional misregulation in cancer | 1.40E-05 | 20 | Q12778, Q15532, P41732, P14780, P27930, P14923, Q16548, Q13489, Q13077, P08069, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | FOXO1, SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, BIRC3, TRAF1, IGF1R, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | | Bazedoxifene | hsa05203 | Viral carcinogenesis | 2.50E-04 | 7 | Q99941, P18848, P27348, P06396, P01889, P10321, P61978 | CREBL1, ATF4, YWHAQ, GSN, HLA-B, HLA-C, HNRPK | More | | Bazedoxifene | hsa05205 | Proteoglycans in cancer | 5.76E-04 | 14 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P01375, P08069, P23588, P04628, Q13635, P22694, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, TNF, IGF1R, EIF4B, WNT1, PTCH1, PRKACB, CD63 | More | | Bazedoxifene | hsa05210 | Colorectal cancer | 1.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Bazedoxifene | hsa05211 | Renal cell carcinoma | 1.06E-02 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Bazedoxifene | hsa05212 | Pancreatic cancer | 9.73E-04 | 5 | P42224, P37173, P84022, Q13485, O75293 | STAT1, TGFBR2, SMAD3, SMAD4, GADD45B | More | | Bazedoxifene | hsa05214 | Glioma | 7.45E-03 | 4 | P08069, P0DP23, P19174, O75293 | IGF1R, CALM1, PLCG1, GADD45B | More | | Bazedoxifene | hsa05215 | Prostate cancer | 3.72E-03 | 3 | P08069, P18848, P14625 | IGF1R, ATF4, HSP90B1 | More | | Bazedoxifene | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | | Bazedoxifene | hsa05218 | Melanoma | 6.63E-03 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa05220 | Chronic myeloid leukemia | 1.25E-02 | 3 | Q13485, P25963, P84022 | SMAD4, NFKBIA, SMAD3 | More | | Bazedoxifene | hsa05222 | Small cell lung cancer | 1.50E-02 | 3 | Q13489, P10415, P25963 | BIRC3, BCL2, NFKBIA | More | | Bazedoxifene | hsa05223 | Non-small cell lung cancer | 1.94E-03 | 6 | P17252, O43524, P19174, P10826, Q9HC35, O75293 | PRKCA, FOXO3, PLCG1, RARB, EML4, GADD45B | More | | Bazedoxifene | hsa05224 | Breast cancer | 1.49E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa05225 | Hepatocellular carcinoma | 1.33E-02 | 1 | P08069 | IGF1R | More | | Bazedoxifene | hsa05226 | Gastric cancer | 2.78E-02 | 3 | P84022, Q13485, P10415 | SMAD3, SMAD4, BCL2 | More | | Bazedoxifene | hsa05231 | Choline metabolism in cancer | 3.99E-02 | 4 | P19174, P23743, O14494, P17252 | PLCG1, DGKA, PLPP1, PRKCA | More | | Bazedoxifene | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.99E-04 | 8 | P42338, P19174, P07766, P20963, P06239, Q04759, Q9HC35, P01730 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ, EML4, CD4 | More | | Bazedoxifene | hsa05320 | Autoimmune thyroid disease | 5.64E-04 | 6 | P13765, P29965, P01889, P10321, P01568, P10747 | HLA-DOB, CD40LG, HLA-B, HLA-C, IFNA21, CD28 | More | | Bazedoxifene | hsa05321 | Inflammatory bowel disease | 1.48E-04 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Bazedoxifene | hsa05330 | Allograft rejection | 4.29E-04 | 4 | P01889, P10321, P48023, P01375 | HLA-B, HLA-C, FASLG, TNF | More | | Bazedoxifene | hsa05332 | Graft-versus-host disease | 7.28E-06 | 7 | P13765, P48023, P01889, P10321, P01375, P26715, Q13241 | HLA-DOB, FASLG, HLA-B, HLA-C, TNF, KLRC1, KLRD1 | More | | Bazedoxifene | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | | Bazedoxifene | hsa05410 | Hypertrophic cardiomyopathy | 1.73E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | | Bazedoxifene | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 8.94E-03 | 2 | P15924, P26012 | DSP, ITGB8 | More | | Bazedoxifene | hsa05415 | Diabetic cardiomyopathy | 4.37E-06 | 14 | P17252, P05141, P14598, Q15080, O15239, Q16718, O14521, P05496, P13073, P12074, Q16539, P49841, Q13557, P04406 | PRKCA, SLC25A5, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, ATP5G1, COX4I1, COX6A1, MAPK14, GSK3B, CAMK2D, GAPDH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P17252 | PRKCA | Protein kinase C alpha type | -0.754 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P17252 | PRKCA | Protein kinase C alpha type | -0.732 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.75 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.818 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.798 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.752 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.758 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.916 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.757 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.841 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | -0.816 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.732 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | -0.931 | P09960 | LTA4H | Leukotriene A-4 hydrolase | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | -0.799 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.842 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.7 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.782 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | -0.744 | P31645 | SLC6A4 | Sodium-dependent serotonin transporter | P49841 | GSK3B | Glycogen synthase kinase-3 beta | -0.714 | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.784 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 0.978 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | 0.725 |
| Bazedoxifene | hsa05416 | Viral myocarditis | 6.58E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | |